Balaji Prasad

Stock Analyst at Barclays

(2.78)
# 1,814
Out of 5,150 analysts
147
Total ratings
49.19%
Success rate
4.67%
Average return

Stocks Rated by Balaji Prasad

Evolus
Mar 5, 2025
Maintains: Overweight
Price Target: $22$25
Current: $5.59
Upside: +347.23%
Amneal Pharmaceuticals
Mar 3, 2025
Maintains: Overweight
Price Target: $10$11
Current: $13.30
Upside: -17.29%
Pacira BioSciences
Feb 28, 2025
Maintains: Overweight
Price Target: $17$24
Current: $22.86
Upside: +4.99%
Viatris
Feb 28, 2025
Maintains: Underweight
Price Target: $12$9
Current: $14.71
Upside: -38.82%
Jazz Pharmaceuticals
Feb 27, 2025
Maintains: Overweight
Price Target: $190$200
Current: $188.69
Upside: +5.99%
Elanco Animal Health
Feb 26, 2025
Maintains: Overweight
Price Target: $20$19
Current: $24.44
Upside: -22.26%
Tarsus Pharmaceuticals
Feb 26, 2025
Maintains: Overweight
Price Target: $62$60
Current: $76.20
Upside: -21.26%
Zoetis
Feb 14, 2025
Maintains: Overweight
Price Target: $242$244
Current: $125.96
Upside: +93.71%
Organon & Co.
Feb 14, 2025
Maintains: Overweight
Price Target: $26$24
Current: $6.87
Upside: +249.34%
Phibro Animal Health
Feb 10, 2025
Maintains: Underweight
Price Target: $20$22
Current: $51.89
Upside: -57.60%
Maintains: Overweight
Price Target: $481$520
Current: $648.70
Upside: -19.84%
Maintains: Overweight
Price Target: $28$26
Current: $32.91
Upside: -21.00%
Maintains: Overweight
Price Target: $150$160
Current: $208.95
Upside: -23.43%
Maintains: Overweight
Price Target: $17$17
Current: $14.28
Upside: +19.05%
Maintains: Overweight
Price Target: $22$18
Current: $3.89
Upside: +362.72%
Maintains: Equal-Weight
Price Target: $2.5$10
Current: $4.25
Upside: +135.29%
Maintains: Overweight
Price Target: $8$7
Current: $1.76
Upside: +297.73%